CK1δ-IN-8

• Description:

  CK1δ-IN-8 (Compound 429) is a CK1δ inhibitor that can be used in Alzheimer's disease research[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H315-H319

• Target:

  Casein Kinase

• Related Pathways:

  Cell Cycle/DNA Damage; Stem Cell/Wnt

• Field of Research:

  Neurological Disease

• Smiles:

  O=C (N (C (C1=CC=CS1) =O) C2=NC=CC=N2) C3=CC=CS3

• Molecular Formula:

  C14H9N3O2S2

• Molecular Weight:

  315.37

• Precautions:

  P264-P280-P302+P352-P305+P351+P338-P362+P364

• References & Citations:

  [1]French et al, CASEIN KINASE 1δ (CK1δ) INHIBITORS, 2012-11-08.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  438018-70-3